Also categorized in BoardNews:
Why Should We Care About Corporate Interlocks?
x hide permanently

Bill Ackman Just \Took a $200 Million Hit to His Reputation

Business Insider
  • Billionaire investor Bill Ackman and his firm Pershing Square, along with Valeant Pharmaceuticals, will pay just under $300 million to settle an insider-trading suit over their attempt to buy pharmaceutical firm Allergan in 2014.
  • Ackman will pay the lion's share, contrary to a previous agreement he struck with Valeant.
  • This is yet another in a series of missteps that have been tarnishing Ackman's reputation since he partnered with Valeant...
Mentions: CEO hostile takeover Bill Ackman